240 related articles for article (PubMed ID: 31803135)
1. Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up.
He YD; Yan XL; Qin C; Zhang P; Guo ZN; Yang Y
Front Neurol; 2019; 10():1224. PubMed ID: 31803135
[No Abstract] [Full Text] [Related]
2. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine.
He Q; Zhang Y; Wang F; Li C; Guo R; Li X; Luan B; Zhao H; Meng L; Chen H; Meng L
Int J Neurosci; 2020 Mar; 130(3):270-275. PubMed ID: 31549584
[No Abstract] [Full Text] [Related]
3. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine (EASTFORM) Trial.
Xing YQ; Guo YZ; Gao YS; Guo ZN; Niu PP; Yang Y
Sci Rep; 2016 Dec; 6():39081. PubMed ID: 27966652
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of patent foramen ovale: a new migraine treatment?
Morandi E; Anzola GP; Angeli S; Melzi G; Onorato E
J Interv Cardiol; 2003 Feb; 16(1):39-42. PubMed ID: 12664816
[TBL] [Abstract][Full Text] [Related]
6. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
7. The value of right heart contrast echocardiography combined with migraine rating scale in evaluating the efficacy of patent foramen ovale closure.
Niu Y; Pan J; Fan S; Wang L; Tang X
BMC Cardiovasc Disord; 2023 Aug; 23(1):390. PubMed ID: 37558988
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Patent Foramen Ovale on the Clinical Features of Migraine without Aura: A Cross-Sectional Study.
Tong Q; Yao Y; Xia Y; Chen Z; Ji G; Chen L; Jin R; Dong W
Int J Gen Med; 2023; 16():3645-3654. PubMed ID: 37637709
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of atrial septal aneurysm and patent foramen ovale with migraine.
He L; Cheng GS; Du YJ; Zhang YS
World J Clin Cases; 2018 Dec; 6(15):916-921. PubMed ID: 30568946
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
13. Cerebral vasomotor reactivity in migraine: effect of patent foramen ovale and aerogenic microembolism.
Khasiyev F; Arsava EM; Topcuoglu MA
Neurol Res; 2020 Sep; 42(9):795-804. PubMed ID: 32496894
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study.
Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G
J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904
[TBL] [Abstract][Full Text] [Related]
15. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
Anzola GP; Morandi E; Casilli F; Onorato E
Stroke; 2004 Sep; 35(9):2140-4. PubMed ID: 15284445
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and outcome of transcatheter closure of patent foramen ovale in patients with cryptogenic stroke].
Fu Q; Guo CX; Du LJ; Bai YQ; Gong XP; Ju Y; Lu JJ; Hu JK; Qu H; Dong KH; Chen BX; Wang YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):882-886. PubMed ID: 30462977
[No Abstract] [Full Text] [Related]
17. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a nomogram for predicting remission of migraine patients with patent foramen ovale after closure.
Wang Y; Lou Y; Chen Y; Shi J; Zhang H
Int J Cardiol; 2024 Jul; 407():132026. PubMed ID: 38609055
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of transesophageal ultrasound-guided patent foramen ovale closure for migraine in adolescents.
Mi Z; He G; Li C; Yang D; Liu X; Zhao L; Gao H; Li X; Zhou X
Front Pediatr; 2023; 11():1296825. PubMed ID: 38046679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
